Thomas Büchner
Impact in
- Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 111
- Acute Myeloid Leukemia Research 110
- Hematopoietic Stem Cell Transplantation 20
- Chronic Myeloid Leukemia Treatments 20
- Multiple Myeloma Research and Treatments 15
-
- Histone Deacetylase Inhibitors Research 12
- Advanced biosensing and bioanalysis techniques 11
- Co-authors
- Wolfgang Hiddemann (59 shared papers)Claudia Schoch (19 shared papers)Wolfgang E. Berdel (48 shared papers)Torsten Haferlach (17 shared papers)Achim Heinecke (27 shared papers)Bernhard Wörmann (29 shared papers)Hartmut Döhner (13 shared papers)Wolfgang Kern (13 shared papers)
- Journals
- Blood (26 papers)Journal of Clinical Oncology (9 papers)Leukemia Research (7 papers)Leukemia (7 papers)Genes Chromosomes and Cancer (4 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Thomas Büchner
125 papers receiving 8.5k citations
Thomas Büchner's Hit Papers
Peers
Comparison fields: 5 of 127
- Hematology 6.6k
- Genetics 1.5k
- Public Health, Environmental and Occupational Health 1.9k
- Cancer Research 682
- Molecular Biology 3.2k
Countries citing papers authored by Thomas Büchner
This map shows the geographic impact of Thomas Büchner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Büchner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Büchner more than expected).
Fields of papers citing papers by Thomas Büchner
This network shows the impact of papers produced by Thomas Büchner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Büchner. The network helps show where Thomas Büchner may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Büchner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2370 |
| 2 | Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease Hit paper breakdown → | 2002 | 749 |
| 3 | 2000 | 404 | |
| 4 | 2008 | 319 | |
| 5 | 2004 | 245 | |
| 6 | 2008 | 234 | |
| 7 | 1999 | 231 | |
| 8 | 2000 | 213 | |
| 9 | 2002 | 213 | |
| 10 | 2009 | 190 | |
| 11 | 1999 | 188 | |
| 12 | 2001 | 128 | |
| 13 | 2006 | 122 | |
| 14 | 2003 | 115 | |
| 15 | Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. | 2000 | 114 |
| 16 | Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. | 1996 | 102 |
| 17 | The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. | 2004 | 99 |
| 18 | 1998 | 93 | |
| 19 | 2009 | 90 | |
| 20 | 2020 | 84 |
About Thomas Büchner
Thomas Büchner is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 131 papers that have together received 8.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (110 papers), Acute Lymphoblastic Leukemia research (36 papers), Hematopoietic Stem Cell Transplantation (20 papers), Chronic Myeloid Leukemia Treatments (20 papers), Multiple Myeloma Research and Treatments (15 papers), Histone Deacetylase Inhibitors Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). The work is most often cited by research in Hematology (6.6k citations), Genetics (1.5k citations), Public Health, Environmental and Occupational Health (1.9k citations), Cancer Research (682 citations) and Molecular Biology (3.2k citations). Thomas Büchner has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Wolfgang Hiddemann, Claudia Schoch, Wolfgang E. Berdel, Torsten Haferlach, Achim Heinecke, Bernhard Wörmann, Hartmut Döhner, Wolfgang Kern, Dietger Niederwieser and Richard A. Larson. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Leukemia and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.